SION – sionna therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Sionna Therapeutics to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit 2026
Sionna Therapeutics (NASDAQ:SION) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $58.00 price target on the stock.
Assessing Sionna Therapeutics (SION) Valuation After Recent Share Price Swings And Premium P/B Multiple [Yahoo! Finance]
Sionna Therapeutics (NASDAQ:SION) had its price target raised by analysts at BTIG Research from $50.00 to $58.00. They now have a "buy" rating on the stock.
Sionna Therapeutics (NASDAQ:SION) had its "strong-buy" rating reaffirmed by analysts at Raymond James Financial, Inc..
Form 4 Sionna Therapeutics, For: Feb 02 Filed by: Thompson Peter A.
Form 4 Sionna Therapeutics, For: Feb 02 Filed by: ORBIMED ADVISORS LLC
Form 4 Sionna Therapeutics, For: Jan 22 Filed by: WINKELRIED JON
Form 144 Sionna Therapeutics, Filed by: Rise Fund Sling, L.P.
Form 144 Sionna Therapeutics, Filed by: Rise Fund Sling II, L.P.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.